Cofix Group Ltd (TLV:CFX)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	148	121	78	149	200	174
Market Cap Growth	-1.16%	56.08%	-47.84%	-25.49%	14.74%	85.06%
Enterprise Value	234	213	176	276	332	278
Last Close Price	4.75	3.88	3.07	5.82	7.57	6.60
PS Ratio	0.51	0.41	0.25	0.48	0.66	0.60
PB Ratio	13.05	8.47	4.24	12.23	8.10	5.33
P/TBV Ratio	14.41	9.18	4.68	19.08	11.30	7.38
P/FCF Ratio	8.43	4.87	8.43	7.32	15.64	7.28
P/OCF Ratio	5.68	3.60	5.39	5.44	5.73	5.23
EV/Sales Ratio	0.80	0.71	0.57	0.90	1.09	0.97
EV/EBITDA Ratio	8.50	15.37	23.17	37.84	25.88	26.81
EV/EBIT Ratio	-	70.55	-	-	101.92	140.31
EV/FCF Ratio	13.29	8.55	19.11	13.55	25.95	11.64
Debt / Equity Ratio	9.11	7.66	6.78	11.32	5.72	3.94
Debt / EBITDA Ratio	3.76	3.61	5.56	6.55	6.13	5.76
Debt / FCF Ratio	5.89	4.40	13.47	6.77	11.03	5.39
Asset Turnover	1.43	1.42	1.37	1.28	1.28	1.33
Inventory Turnover	14.43	15.89	16.35	15.18	16.34	18.65
Quick Ratio	0.25	0.27	0.26	0.20	0.23	0.40
Current Ratio	0.40	0.43	0.40	0.33	0.39	0.57
Return on Equity (ROE)	-47.35%	-24.51%	-88.44%	-67.80%	-27.87%	-25.39%
Return on Assets (ROA)	0.04%	0.90%	-0.78%	-0.97%	0.86%	0.57%
Return on Capital (ROIC)	0.06%	1.42%	-1.22%	-1.47%	1.24%	0.79%
Return on Capital Employed (ROCE)	0.10%	2.90%	-	-	2.40%	1.30%
Earnings Yield	-3.90%	-2.79%	-13.94%	-6.64%	-2.96%	-5.36%
FCF Yield	11.86%	20.53%	11.87%	13.67%	6.39%	13.73%
Buyback Yield / Dilution	-	-3.44%	-22.17%	-7.91%	26.36%	0.20%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.